![]() |
Inflammatory Bowel Diseases |
Free Subscription
1 Aliment Pharmacol Ther |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Inflammatory Bowel Diseases is free of charge.
Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General
Population: A Nationwide Cohort Study in Sweden 2006-2021.
Aliment Pharmacol Ther. 2025 Jun 1. doi: 10.1111/apt.70203.
PubMed
Abstract available
Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with
refractory inflammatory bowel disease or concomitant immune mediated disease or
extra-intestinal manifestations: A Multi-Center Canadian Study.
Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003573.
PubMed
Abstract available
Comprehensive evaluation of clinical phenotypes and pathogenic features in
late-onset monogenic inflammatory bowel disease: a comparative study with
infantile-onset cases.
BMC Gastroenterol. 2025;25:432.
PubMed
Abstract available
Predictive accuracy of fecal calprotectin in assessing clinical activity and
disease severity in patients with Ulcerative Colitis and Crohn's disease.
BMC Gastroenterol. 2025;25:429.
PubMed
Abstract available
Global, regional, and national burden of inflammatory bowel disease in persons
aged 60-89 years from 1992 to 2021.
BMC Gastroenterol. 2025;25:425.
PubMed
Abstract available
Effectiveness of an app-based walking program for obese patients with
inflammatory bowel disease in Korea: a single-blind parallel-group randomized
clinical trial.
BMC Gastroenterol. 2025;25:417.
PubMed
Abstract available
A novel inflammatory biomarker in assessing disease activity in ulcerative
colitis: gasdermin D.
BMC Gastroenterol. 2025;25:418.
PubMed
Abstract available
Diagnostic Accuracy of Non-Invasive Biomarkers and Imaging for Evaluating
Postoperative Recurrence in Crohn's Disease.
Clin Gastroenterol Hepatol. 2025 Jun 2:S1542-3565(25)00455.
PubMed
Abstract available
Ustekinumab Dose Optimization in Ulcerative Colitis: Is More Always Better?
Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09108.
PubMed
A multicenter study on bowel preparation in inflammatory bowel disease patients:
comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient setting.
Eur J Gastroenterol Hepatol. 2025 May 19. doi: 10.1097/MEG.0000000000003005.
PubMed
Abstract available
Sex-based differences in the relationship between health-related quality of life,
physical activity, and inflammatory markers in people with Crohn's disease.
Gastroenterol Hepatol. 2025 May 30:502494. doi: 10.1016/j.gastrohep.2025.502494.
PubMed
Abstract available
An International Consensus on Appropriate Management of Corticosteroids in
Clinical Trials in Inflammatory Bowel Disease.
Gastroenterology. 2025 May 28:S0016-5085(25)00825.
PubMed
Abstract available
Adherent-invasive Escherichia coli in Crohn's disease: the 25th anniversary.
Gut. 2025 Jun 5:gutjnl-2025-335331. doi: 10.1136/gutjnl-2025-335331.
PubMed
Abstract available
Lack of Efficacy of Concomitant 5-Aminosalicylic Acid With Vedolizumab in
Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
Inflamm Bowel Dis. 2025 May 21:izaf088. doi: 10.1093.
PubMed
The Association of Inflammatory Bowel Disease and Eosinophilic Esophagitis: A
Systematic Review and Meta-analysis.
Inflamm Bowel Dis. 2025 Jun 4:izaf095. doi: 10.1093.
PubMed
Abstract available
Temporal Trends in Mortality Related to Crohn's Disease in the United States: A
21-year Retrospective Analysis of CDC-WONDER Database.
J Clin Gastroenterol. 2025 Jun 9. doi: 10.1097/MCG.0000000000002209.
PubMed
Abstract available
Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review
of Human Epidemiologic Studies.
J Crohns Colitis. 2025;19:jjaf061.
PubMed
Abstract available
Long-term disease course of ulcerative colitis in a prospective European
population-based inception cohort - an Epi-IBD cohort study.
J Crohns Colitis. 2025 Jun 3:jjaf089. doi: 10.1093.
PubMed
Abstract available
Cancer Incidence in Patients with Ulcerative Colitis Naive to or Treated with
Thiopurine and Targeted Therapies- a cohort study 2007 to 2022 with comparison to
the general population.
J Crohns Colitis. 2025 Jun 2:jjaf091. doi: 10.1093.
PubMed
Abstract available
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's
disease: a phase 2a induction trial.
Lancet Gastroenterol Hepatol. 2025 May 30:S2468-1253(25)00071.
PubMed
Abstract available
Tulisokibart shows promise for Crohn's disease.
Lancet Gastroenterol Hepatol. 2025 May 30:S2468-1253(25)00103.
PubMed
Improved detection of microbiome-disease associations via population
structure-aware generalized linear mixed effects models (microSLAM).
PLoS Comput Biol. 2025;21:e1012277.
PubMed
Abstract available
Screening and validation of 3'-Methoxydaidzein as a therapeutic agent in
ulcerative colitis based on disulfidptosis-associated molecular clusters.
PLoS One. 2025;20:e0324586.
PubMed
Abstract available
CCR2 overexpressing gingiva mesenchymal stem cells provide high intestinal
regeneration in a rat model of ulcerative colitis.
PLoS One. 2025;20:e0325566.
PubMed
Abstract available
Identification of novel drug targets through integrative PWAS of brain and plasma
proteins with Ulcerative Colitis GWAS.
PLoS One. 2025;20:e0324035.
PubMed
Abstract available
Thank you for your interest in scientific medicine.